"Nanoparticles" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Nanometer-sized particles that are nanoscale in three dimensions. They include nanocrystaline materials; NANOCAPSULES; METAL NANOPARTICLES; DENDRIMERS, and QUANTUM DOTS. The uses of nanoparticles include DRUG DELIVERY SYSTEMS and cancer targeting and imaging.
| Descriptor ID |
D053758
|
| MeSH Number(s) |
J01.637.512.600
|
| Concept/Terms |
Nanocrystalline Materials- Nanocrystalline Materials
- Material, Nanocrystalline
- Materials, Nanocrystalline
- Nanocrystalline Material
- Nanocrystals
- Nanocrystal
|
Below are MeSH descriptors whose meaning is more general than "Nanoparticles".
Below are MeSH descriptors whose meaning is more specific than "Nanoparticles".
This graph shows the total number of publications written about "Nanoparticles" by people in this website by year, and whether "Nanoparticles" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 4 | 1 | 5 |
| 2008 | 4 | 0 | 4 |
| 2009 | 5 | 4 | 9 |
| 2010 | 7 | 0 | 7 |
| 2011 | 5 | 0 | 5 |
| 2012 | 9 | 2 | 11 |
| 2013 | 6 | 1 | 7 |
| 2014 | 4 | 3 | 7 |
| 2015 | 11 | 3 | 14 |
| 2016 | 10 | 6 | 16 |
| 2017 | 3 | 3 | 6 |
| 2018 | 9 | 7 | 16 |
| 2019 | 19 | 6 | 25 |
| 2020 | 7 | 9 | 16 |
| 2021 | 14 | 2 | 16 |
| 2022 | 13 | 1 | 14 |
| 2023 | 7 | 0 | 7 |
| 2024 | 9 | 6 | 15 |
| 2025 | 13 | 4 | 17 |
| 2026 | 9 | 3 | 12 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nanoparticles" by people in Profiles.
-
Encapsulation of AAVs into Protein Vault Nanoparticles as a Novel Solution to Gene Therapy's Neutralizing Antibody Problem. ACS Synth Biol. 2026 Oct 16; 15(10):3975-3982.
-
Targeting mitochondrial dysfunction and apoptosis in 5-fluorouracil-induced cardiotoxicity using kaempferol-mediated selenium nanoparticles. Sci Rep. 2026 09 12; 16(1).
-
Cyclosporine-A Nanotherapeutics Ameliorate Lupus Nephritis by Reprogramming the Gut-Microbial Metabolic Axis and Systemic Inflammation. ACS Nano. 2026 Sep 08; 20(35):24334-24352.
-
Nanomedicine beyond carriers - devices, cells & living therapeutics. Biomed Microdevices. 2026 Sep 08; 28(3).
-
Surface chemistry governs sex-dependent responses to PEG and zwitterionic siRNA nanocarriers in primary macrophages. Sci Adv. 2026 Aug 28; 12(35):eaef4315.
-
Interfacial lipid digestion-responsive injectable nanoemulsions enhance lapatinib efficacy in triple-negative breast cancer. Colloids Surf B Biointerfaces. 2026 Dec; 268(Pt 2):116079.
-
Laser-programmable glycosaminoglycan-based nanocarriers co-deliver hypocrellin B and doxorubicin for spatiotemporal chemo-photothermal therapy of hepatocellular carcinoma. Colloids Surf B Biointerfaces. 2026 Nov; 267:115919.
-
Towards advancing cancer nanomedicine: Recent strategies for overcoming translational and toxicological challenges. Biomater Adv. 2026 Nov; 188:214987.
-
Transcriptomic profiling of radiopaque nanoparticle-loaded, bioresorbable polymeric perivascular wrap for arteriovenous fistula maturation. Biomed Microdevices. 2026 May 07; 28(2).
-
Reprogramming Disulfide Reduction in Endoplasmic Reticulum Uncouples Immune Evasion of Pancreatic Cancer. Adv Mater. 2026 May; 38(30):e17261.